Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

ZPK helps skin cells mature and may affect skin health.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Tofacitinib may help treat hair loss in children with alopecia areata.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Oenocarpus bataua vegetable oil may help reduce hair loss by affecting a key gene pathway.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Infections during JAK inhibitor treatment for alopecia areata are usually manageable and rarely stop treatment permanently.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Integrin-linked kinase is crucial for melanoblasts to properly colonize the skin.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

RIPK1 inhibitors might help prevent alopecia areata.